Sean Tunis

Summary

Publications

  1. ncbi Using health technology assessment to identify gaps in evidence and inform study design for comparative effectiveness research
    Sean R Tunis
    Center for Medical Technology Policy, World Trade Center Baltimore, Baltimore, MD 21202, USA
    J Clin Oncol 30:4256-61. 2012
  2. ncbi The National Oncologic PET Registry: lessons learned for coverage with evidence development
    Sean Tunis
    Center for Medical Technology Policy, Baltimore, Maryland 21202, USA
    J Am Coll Radiol 6:360-5. 2009
  3. ncbi Comparative effectiveness research: Policy context, methods development and research infrastructure
    Sean R Tunis
    Center for Medical Technology Policy, World Trade Center Baltimore, 401 E Pratt St, Suite 631, Baltimore, MD 21201, USA
    Stat Med 29:1963-76. 2010
  4. ncbi Generating evidence for comparative effectiveness research using more pragmatic randomized controlled trials
    C Daniel Mullins
    University of Maryland School of Pharmacy, Baltimore, Maryland, USA
    Pharmacoeconomics 28:969-76. 2010
  5. ncbi Recommendations for clinical trials of off-label drugs used to treat advanced-stage cancer
    C Daniel Mullins
    University of Maryland, School of Pharmacy, 220 Arch St, 12th Floor, Baltimore, MD 21201, USA
    J Clin Oncol 30:661-6. 2012
  6. ncbi Using clinical trials as a condition of coverage: lessons from the National Emphysema Treatment Trial
    Tanisha Carino
    Centers for Medicare and Medicaid Services, Coverage and Analysis Group, 7500 Security Boulevard, Baltimore, MD 21244, USA
    Clin Trials 1:108-14; discussion 115-21. 2004
  7. ncbi Uncertainty in assessing value of oncology treatments
    C Daniel Mullins
    Center for Medical Technology Policy, Baltimore, Maryland, USA
    Oncologist 15:58-64. 2010

Detail Information

Publications7

  1. ncbi Using health technology assessment to identify gaps in evidence and inform study design for comparative effectiveness research
    Sean R Tunis
    Center for Medical Technology Policy, World Trade Center Baltimore, Baltimore, MD 21202, USA
    J Clin Oncol 30:4256-61. 2012
    ..Recent efforts are beginning to demonstrate the potential to build on the work invested in developing HTA reports to provide a roadmap toward these objectives...
  2. ncbi The National Oncologic PET Registry: lessons learned for coverage with evidence development
    Sean Tunis
    Center for Medical Technology Policy, Baltimore, Maryland 21202, USA
    J Am Coll Radiol 6:360-5. 2009
    ....
  3. ncbi Comparative effectiveness research: Policy context, methods development and research infrastructure
    Sean R Tunis
    Center for Medical Technology Policy, World Trade Center Baltimore, 401 E Pratt St, Suite 631, Baltimore, MD 21201, USA
    Stat Med 29:1963-76. 2010
    ..The approach to addressing each of these issues should be informed by the understanding that the primary purpose of CER is to help health care decision makers make informed clinical and health policy decisions...
  4. ncbi Generating evidence for comparative effectiveness research using more pragmatic randomized controlled trials
    C Daniel Mullins
    University of Maryland School of Pharmacy, Baltimore, Maryland, USA
    Pharmacoeconomics 28:969-76. 2010
    ....
  5. ncbi Recommendations for clinical trials of off-label drugs used to treat advanced-stage cancer
    C Daniel Mullins
    University of Maryland, School of Pharmacy, 220 Arch St, 12th Floor, Baltimore, MD 21201, USA
    J Clin Oncol 30:661-6. 2012
    ....
  6. ncbi Using clinical trials as a condition of coverage: lessons from the National Emphysema Treatment Trial
    Tanisha Carino
    Centers for Medicare and Medicaid Services, Coverage and Analysis Group, 7500 Security Boulevard, Baltimore, MD 21244, USA
    Clin Trials 1:108-14; discussion 115-21. 2004
    ....
  7. ncbi Uncertainty in assessing value of oncology treatments
    C Daniel Mullins
    Center for Medical Technology Policy, Baltimore, Maryland, USA
    Oncologist 15:58-64. 2010
    ....